Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
Makes and sells medicines for cancer, heart disease, and respiratory conditions in China.
0.11-0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-31.1%
The outlook
8329.HK is trading near its 52-week lows, well below both its 50- and 200-day moving averages, signaling a downtrend. The stock sits just 21% of the way up from its yearly low, reflecting significant weakness. Analyst coverage appears limited, and the overall sentiment leans bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range21% of the way from its 52-week low to high
Market cap
$184.6M
52-wk high
0.18
52-wk low
0.09
50-day avg
0.11
200-day avg
0.14
Trailing P/E
—
Similar stocks
8247.HKBiosino Bio-Technology and Science Incorporation$3.14+0.32%8286.HKShanxi Changcheng Microlight Equipment Co. Ltd.$0.11+0.00%8348.HKTianjin Binhai Teda Logistics (Group) Corporation Limited$0.32-3.03%8249.HKZhejiang RuiYuan Intelligent Control Technology Company Limited$0.07-1.52%8205.HKShanghai Jiaoda Withub Information Industrial Company Limited$0.39+1.30%